Using the median oxytocin dose (14.8 IU) as the reference (OR = 1.0), doses below 10 IU showed a stable OR range of 0.8–1.0 (95% CI: 0.62–1.15), indicating no significant association with hyperbilirubinemia. The gene discussed is OXT; the disease is Hyperbilirubinemia.